Back to search

Article

Intrathecal mesenchymal stem cell therapy in progressive multiple sclerosis: cross-compartment immune profiling in the SMART-MS randomized trial

2026-05-12

Abstract excerpt

<title>Abstract</title> <p>Therapeutic options for progressive multiple sclerosis (MS) remain limited, and the biological mechanisms engaged by intrathecal mesenchymal stem cell (MSC) therapy are incompletely understood. MSCs are proposed to exert immunomodulatory and trophic effects, yet most studies rely on targeted biomarkers and lack systems-level analysis across immune compartments. Here, we applied an integ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
75da16c6-89ff-530e-b370-05b190dddfec
DOI
10.21203/rs.3.rs-9629755/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intrathecal mesenchymal stem cell therapy in progressive multiple sclerosis: cross-compartment immune profiling in the SMART-MS randomized trialDOI 10.21203/rs.3.rs-9629755/v1
Select a neighboring publication to make it the new centre.